by Cerebral angiography is a medical imaging technique used to visualize the blood vessels in the brain and neck. It helps physicians identify abnormalities, lesions, aneurysms, stenosis, vascular blockages or deviations from normal vascular patterns. The procedure involves injecting a contrast dye through a catheter placed into arteries that supply blood to the brain. Cerebral angiography offers several advantages over other imaging modalities used for detecting vascular abnormalities. It provides highly detailed images of arteries and veins enabling physicians to clearly visualize even tiny abnormalities. The digital subtraction technique significantly enhances image quality while reducing radiation exposure. Being an invasive technique, it allows concurrent treatment such as angioplasty and stenting during the same setting.
The global Cerebral Angiography Market is estimated to be valued at US$ 14.96 Bn in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends gaining traction in the Global Cerebral Angiography Market Size is the development of non-invasive angiography techniques. Companies are focusing on developing advanced CT and MRI angiography techniques which can provide high resolution 3D images of brain vasculature without the need for catheter insertion. For instance, CT angiography utilizes a CT scanner combined with intravenous iodinated contrast injection to generate 3D reconstructions of cerebral blood vessels. This has significantly reduced the need for conventional invasive angiography procedures. Advancements in flat detector angiography systems is another trend, enabling live fluoroscopic imaging with high resolution to guide endovascular procedures. This is expected to boost the adoption of cerebral angiography.
Porter’s Analysis
Threat of new entrants: The high initial investments required for production and R&D act as a barrier for new players. However, the growing demand and technological innovations provide opportunities for new entrants.
Bargaining power of buyers: The bargaining power of buyers is moderate due to the availability of substitutes. However, specialized and customized products increase switching costs.
Bargaining power of suppliers: The bargaining power of suppliers is low due to the presence of many suppliers globally. However, stringent regulatory frameworks increase suppliers’ power.
Threat of new substitutes: Technological advancements are leading to the emergence of less invasive diagnostic modalities like MRI and CT angiography that can act as substitutes.
Competitive rivalry: The market is highly competitive with major global players investing heavily in R&D. Product differentiation and focus on specialized portfolios are the key strategies adopted.
Key Takeaways
The global Cerebral Angiography Market is expected to witness high growth. North America dominated the market owing to the growing geriatric population and availability of advanced healthcare facilities. The presence of leading players and new product launches will further drive the regional growth.
Europe accounted for a major market share due to the increasing prevalence of neurovascular disorders. The rising healthcare expenditure and government initiatives for digitization are fueling market expansion.
Key players operating in the Cerebral Angiography Market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Shimadzu Corporation, Hitachi, Ltd., Carestream Health, Inc., Medtronic plc, Stryker Corporation, Terumo Corporation, Boston Scientific Corporation, AngioDynamics, Inc., Penumbra, Inc., MicroPort Scientific Corporation, Cook Medical LLC.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
